Key Clinical Message:
18F-FDG PET/CT has clinical relevance in HCL at diagnosis and for the
follow-up of patients treated, especially in case of atypical
presentations such as bone involvements (which are probably
underestimated) and poor bone marrow infiltration.
Keywords : Hairy cell leukemia, HCL, Bone lesions, 18F-FDG
PET/CT, PNA, Cladribine, Rituximab